KURA Oncology’s Stock Climbs As New Drug Development Takes Center Stage
Fahim Awan
April 22, 2024
During the current market session, Kura Oncology, Inc. (NASDAQ: KURA) is observing a significant upsurge in its stock, demonstrating a notable escalation of 8.53% to